Morgan Stanley Raises CME Group (NASDAQ:CME) Price Target to $220.00
CME Group (NASDAQ:CME – Free Report) had its target price upped by Morgan Stanley from $215.00 to $220.00 in a research report report published on Thursday, Benzinga reports. They currently have an equal weight rating on the financial services provider’s stock. Several other research analysts have also recently commented on the company. Rosenblatt Securities reissued […]
More Stories
CV Advisors LLC Invests $608,000 in Exxon Mobil Corporation (NYSE:XOM)
CV Advisors LLC purchased a new position in Exxon Mobil Corporation (NYSE:XOM – Free Report) in the 1st quarter, according...
Continuum Advisory LLC Purchases 1,897 Shares of Exxon Mobil Corporation (NYSE:XOM)
Continuum Advisory LLC raised its position in shares of Exxon Mobil Corporation (NYSE:XOM – Free Report) by 3.2% during the...
Park Capital Management LLC WI Purchases New Position in Exxon Mobil Corporation (NYSE:XOM)
Park Capital Management LLC WI purchased a new stake in shares of Exxon Mobil Corporation (NYSE:XOM – Free Report) in...
Cambridge Investment Research Advisors Inc. Boosts Stake in McKesson Corporation (NYSE:MCK)
Cambridge Investment Research Advisors Inc. lifted its stake in McKesson Corporation (NYSE:MCK – Free Report) by 18.9% in the 1st...
Flagship Harbor Advisors LLC Buys 351 Shares of iShares 1-3 Year Treasury Bond ETF (NASDAQ:SHY)
Flagship Harbor Advisors LLC grew its stake in shares of iShares 1-3 Year Treasury Bond ETF (NASDAQ:SHY – Free Report)...
Consolidated Planning Corp Sells 4,323 Shares of Johnson & Johnson (NYSE:JNJ)
Consolidated Planning Corp decreased its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 44.6% in the 1st quarter,...